Europe Pharmaceutical Contract Manufacturing Market - Size
Base Year For Estimation
2023
Forecast Data Period
2024-2030
Historical Data Period
2018-2021
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
Contract manufacturing organisation is also known as contract development and manufacturing organisation. It is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. More specifically, contract manufacturing is the outsourcing of specific production activities that were previously performed by the manufacturer to a third-party. Rising need for state-of-the-art processes and production technologies are the factors that boost up the market.
Europe Pharmaceutical Contract Manufacturing MarketSegments Size & Growth:
Europe Pharmaceutical Contract Manufacturing Market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. The major factors that propel the growth of the Europe Pharmaceutical Contract Manufacturing Market are growing research and development requirements of sourcing companies, increasing awareness about CMOs has led to a rise in research funding, support for clinical and support services and higher number of US FDA-approved manufacturing facilities
Europe Pharmaceutical Contract Manufacturing Market - Growth
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
in emerging countries, increasing aging population and demand for generic drugs and adoption of novel manufacturing technologies. However, without the right packaging, drugs may get damaged in transit or exposed to contaminants that limit their effectiveness, which might hamper the growth of the market.
Europe Pharmaceutical Contract Manufacturing Market Segments Share:
Europe Pharmaceutical Contract Manufacturing Market is segmented by the type which comprises sterile and non-sterile. By product, the market is segmented into finished dosage formulations, active pharmaceutical ingredients, otc medicines and nutritional products, advanced drug delivery products and secondary packaging market. By industry, the market is segmented into pharmaceutical and biopharmaceutical. By technology, the market is segmented into dosage formulation technologies and dosage forms by route of administration. By Geography, the market is segmented into various regions namely U.K., Germany, France, Italy, Spain, and Russia.
Europe Pharmaceutical Contract Manufacturing Market Trends:
- Recipharm and Vetcare have announced the signing of an agreement for the development and manufacture of a parenteral veterinary product.
- Catalent, Inc. had announced that it had reached an
You can also purchase parts of this report. Do you want to check out a section wise price list
Europe Pharmaceutical Contract Manufacturing Market - Porter's Five Force Analysis
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
agreement to acquire Bloomington, an integrated provider of drug substance and drug product manufacturing and related services.
Aenova group expands its animal health products with a dedicated manufacturing area for solids veterinary pharmaceuticals in Latina (Italy).
Europe Pharmaceutical Contract Manufacturing Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Europe Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary critical players in the Europe Pharmaceutical Contract Manufacturing Market are:
- Recipharm AB
- Catalent, Inc.
- Haupt Pharma
- Jubliant life sciences Ltd
- Vetter pharma-fertigung GMBH & CO.KG
Exclusive Benefits
Credibility and
Transparency
We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.
Exhaustive
Coverage
Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.
Competitive
Edge
Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.
Golden
pportunities
Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.
Top-notch Reportsd
Guaranteed
Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.
Post Purchase
Support
Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.
